SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Omeros
An SI Board Since March 2010
Posts SubjectMarks Bans Symbol
464 28 0 OMER
Emcee:  Bradpalm1 Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
364Omeros Files Orphan Drug Application for OMS721 in Immunoglobulin A Nephropathy Howard Williams-11/3/2016
363Bullish cross in Stochastic oscillator and RSI is trading near to 41.35 level wihollyhunter-11/2/2016
362Omeros Requests Fast Track Designation for OMS721 for the Treatment of IgA NephrHoward Williams-10/31/2016
361Bullish crossover in MACD and Stochastic oscillator. [graphic]hollyhunter-10/25/2016
360WBB Securities Thinks Omeros Corp.’s Stock is Going to Recover markets.coJulius Wong110/22/2016
359Omeros Announces Positive Data from OMS721 Phase 2 Clinical Trial in Renal DiseaJulius Wong110/17/2016
358Omeros Corporation to Announce Second Quarter 2016 Financial Results on August 9Howard Williams-8/4/2016
357OMS906 Shows Marked Efficacy in Model of Arthritis Hmmmm ...... if this sort of Howard Williams-8/4/2016
356I believe the following is very good news for OMER ........ an expeditious path Howard Williams17/28/2016
355Omeros to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference DatHoward Williams-7/7/2016
354Tapping their credit facility ..... no surprise ... ****************************Howard Williams-5/17/2016
353OMIDRIA revenues below expectations, but ........ From the news release ..... Howard Williams-5/10/2016
352Omeros Corporation to Announce First Quarter 2016 Financial Results on May 10, 2Howard Williams-5/4/2016
351Omeros Corporation Announces Independent Studies with OMIDRIA® to Be PresenHoward Williams-4/26/2016
350It’s a Jewish tradition at this time of the year to count the “Omer.” en.wikipedBulbaMan-4/25/2016
349Parking this stuff on a patent search for OMER (2001 onward), sorry about the foBiotech Jim14/25/2016
348Looking forward to your report, Jim! Here’s a very bullish write-up on Omeros puBulbaMan-4/23/2016
347<Have you looked at any of their patents at all (I haven't)? Might be somBiotech Jim-4/22/2016
346>> lack of monetizing the many assets they claim to have. Yes, they have Biomaven-4/21/2016
345Patient Dosing Initiated for OMS721 Phase 2 Program in Renal Diseases 20-Apr-20Howard Williams-4/20/2016
344I opened up a position in OMER this morning. I like their complement program,Biotech Jim-4/19/2016
343Roche has reopened their phase I schizophrenia trial with PDE10a inhibitor, RG72scaram(o)uche-4/19/2016
342FWIW, I had been assuming (perhaps erroneously?) that the Omidria program withinHoward Williams14/13/2016
341SEATTLE--(BUSINESS WIRE)--Apr. 7, 2016-- Omeros Corporation (NASDAQ:OMER), Howard Williams-4/7/2016
340"Is This Upstart the Biggest Threat to Alexion Pharmaceuticals?" Todd Howard Williams-3/11/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News